Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHANTOM: Anastrozole in Pulmonary Arterial Hypertension
NCT03229499Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Dec 2017
- Primary completion
- Jul 2022
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of anastrozole in pulmonary arterial hypertension (PAH), sponsored by University of Pennsylvania. Started Dec 2017; status: completed.
02
Drugs
anastrozole
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT03229499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03229499.